Phosphorylated ribosomal S6 (p-rpS6) as a post-treatment indicator of HER2 signalling targeted drug resistance

被引：11

作者：

Yang-Kolodji, Gloria ^{[1
]}

Mumenthaler, Shannon M. ^{[2
]}

Mehta, Arjun ^{[1
]}

Ji, Lingyun ^{[3
]}

Tripathy, Debu ^{[1
,4
]}

机构：

[1] Univ So Calif, Dept Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA

[2] Univ So Calif, Ctr Appl Mol Med, Los Angeles, CA 90033 USA

[3] Univ So Calif, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA

[4] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX USA

来源：

BIOMARKERS | 2015年 / 20卷 / 05期

关键词：

Biomarker; breast cancer; cell model; drug response; trastuzumab resistance; METASTATIC BREAST-CANCER; OVERCOMING RESISTANCE; PARADIGM-SHIFT; SINGLE-AGENT; TRASTUZUMAB; LAPATINIB; SURVIVAL; EFFICACY; SAFETY; KI67;

D O I：

10.3109/1354750X.2015.1068865

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Objective: To identify clinically relevant predictive biomarkers of trastuzumab resistance. Material and methods: MTT, FACS assays, immunoblotting and immunocytochemistry were used to phenotypically characterize drug responses of two cell models BT474R and SKBR3R. Student's t-test and Spearman's correlation were applied for statistic analysis. Results: The activity of a downstream effector of the HER2 pathway phosphorylated ribosomal protein S6 (p-rpS6), was suppressed by trastuzumab in the parental cell lines yet remained unchanged in the resistant cells following treatment. The level of p-rpS6 was inversely correlated to the drug induced growth inhibition of trastuzumab-resistant cells when they are treated with selected HER2 targeting drugs. Conclusion: p-rpS6 is a robust post-treatment indicator of HER2 pathway-targeted therapy resistance.

引用

页码：313 / 322

页数：10

共 47 条

[21] Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index [J].

Jalava, P ;

Kuopio, T ;

Juntti-Patinen, L ;

Kotkansalo, T ;

Kronqvist, P ;

Collan, Y .

HISTOPATHOLOGY, 2006, 48 (06) :674-682

[22] Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes [J].

Jerusalem, Guy ;

Rorive, Andree ;

Collignon, Joelle .

BREAST CANCER-TARGETS AND THERAPY, 2014, 6 :43-57

[23] Phosphorylation of Ribosomal Protein S6 Attenuates DNA Damage and Tumor Suppression during Development of Pancreatic Cancer [J].

Khalaileh, Abed ;

Dreazen, Avigail ;

Khatib, Areej ;

Apel, Roy ;

Swisa, Avital ;

Kidess-Bassir, Norma ;

Maitra, Anirban ;

Meyuhas, Oded ;

Dor, Yuval ;

Zamir, Gideon .

CANCER RESEARCH, 2013, 73 (06) :1811-1820

[24] Correlation between Ki67 and Breast Cancer Prognosis [J].

Kontzoglou, Konstantinos ;

Palla, Victoria ;

Karaolanis, George ;

Karaiskos, Ioannis ;

Alexiou, Ioannis ;

Pateras, Ioannis ;

Konstantoudakis, Konstantinos ;

Stamatakos, Michael .

ONCOLOGY, 2013, 84 (04) :219-225

[25] A systematic review of dual targeting in HER2-positive breast cancer [J].

Kumler, Iben ;

Tuxen, Malgorzata K. ;

Nielsen, Dorte Lisbet .

CANCER TREATMENT REVIEWS, 2014, 40 (02) :259-270

[26] Predictive biomarkers: a paradigm shift towards personalized cancer medicine [J].

La Thangue, Nicholas B. ;

Kerr, David J. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (10) :587-596

[27] The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer [J].

Lauring, Josh y ;

Park, Ben Ho ;

Wolff, Antonio C. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (06) :670-678

[28] Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials [J].

Lavaud, Pernelle ;

Andre, Fabrice .

BMC MEDICINE, 2014, 12

[29] Dissecting the Akt/Mammalian target of rapamycin signaling network: Emerging results from the head and neck cancer tissue array initiative [J].

Molinolo, Alfredo A. ;

Hewitt, Stephen M. ;

Amornphimoltham, Panomwat ;

Keelawat, Somboon ;

Rangdaeng, Samraeung ;

Garcia, Abelardo Meneses ;

Raimondi, Ana R. ;

Jufe, Rafael ;

Itoiz, Maria ;

Gao, Yan ;

Saranath, Dhananjaya ;

Kaleebi, George S. ;

Yoo, George H. ;

Leak, Lee ;

Myers, Ernest M. ;

Shintan, Satoru ;

Wong, David ;

Massey, H. Davis ;

Yeudall, W. Andrew ;

Lonardo, Fulvio ;

Ensley, John ;

Gutkind, J. Silvio .

CLINICAL CANCER RESEARCH, 2007, 13 (17) :4964-4973

[30]

Nahta R., 2012, ONCOL, V2012

← 1 2 3 4 5 →